TrialHealth and quality of life outcomes2015

Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.

Pedro Marques da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.